Rosa
Device Knees
PDI 00889024619401
General payments
$12,964,172
Research payments
$452,174
Through program year 2025, $12,964,172 in general payments and $452,174 in research payments were reported against Rosa (Knees).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,938,214 | 2,237 |
| 2025 | Research | $124,625 | 3 |
| 2024 | General | $3,063,640 | 2,270 |
| 2024 | Research | $29,350 | 3 |
| 2023 | General | $3,854,206 | 4,225 |
| 2023 | Research | $98,942 | 24 |
| 2022 | General | $3,108,112 | 5,245 |
| 2022 | Research | $199,258 | 24 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 38 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
13,977 general · 54 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.